Kemadrin

Active Ingredient(s): Procyclidine
FDA Approved: * July 27, 1955
Pharm Company: * MONARCH PHARMS
Category: Parkinsons

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Kemadrin Overview

Procyclidine is an anticholinergic drug principally used for the treatment of drug-induced parkinsonism, akathisia and acute dystonia; Parkinson disease; and idiopathic or secondary dystonia. Contents 1 Uses 2 Overdose 3 Synthesis 4 See also 5 References 6 Further reading Uses It is used in patients with parkinsonism and akathisia, and to reduce the side effects of antipsychotic treatment given for schizophrenia. Procyclidine is also a second-line drug for the treatment of Parkinso...

Read more Kemadrin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Procyclidine

Recent Kemadrin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Procyclidine or a similar ingredient: (1 result)

• PROCYCLIDINE 3 discussions